Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2010

Study Completion Date

May 31, 2010

Conditions
Ocular Cicatricial Pemphigoid
Interventions
DRUG

Rituximab

The Rituximab dose is 1000mg (1gm) given as an IV infusion every two weeks for 2 doses (days 1 and 15).

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

collaborator

Biogen

INDUSTRY

lead

University of Alabama at Birmingham

OTHER